4E10 and 2F5 monoclonal antibodies: binding specificities to phospholipids, tolerance, and clinical safety issues.
Alving
Carl R
CR
D016915:AIDS Vaccines; D015483:HIV Antibodies / Q000378:metabolism* / Q000627:therapeutic use; D015700:HIV Envelope Protein gp41 / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007108:Immune Tolerance; D010743:Phospholipids / Q000378:metabolism*; D011485:Protein Binding
D016915:AIDS Vaccines; D015483:HIV Antibodies; D015700:HIV Envelope Protein gp41; D010743:Phospholipids